IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease
- PMID: 32051586
- PMCID: PMC7047598
- DOI: 10.1038/s41586-020-2003-8
IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease
Abstract
Coeliac disease is a complex, polygenic inflammatory enteropathy caused by exposure to dietary gluten that occurs in a subset of genetically susceptible individuals who express either the HLA-DQ8 or HLA-DQ2 haplotypes1,2. The need to develop non-dietary treatments is now widely recognized3, but no pathophysiologically relevant gluten- and HLA-dependent preclinical model exists. Furthermore, although studies in humans have led to major advances in our understanding of the pathogenesis of coeliac disease4, the respective roles of disease-predisposing HLA molecules, and of adaptive and innate immunity in the development of tissue damage, have not been directly demonstrated. Here we describe a mouse model that reproduces the overexpression of interleukin-15 (IL-15) in the gut epithelium and lamina propria that is characteristic of active coeliac disease, expresses the predisposing HLA-DQ8 molecule, and develops villous atrophy after ingestion of gluten. Overexpression of IL-15 in both the epithelium and the lamina propria is required for the development of villous atrophy, which demonstrates the location-dependent central role of IL-15 in the pathogenesis of coeliac disease. In addition, CD4+ T cells and HLA-DQ8 have a crucial role in the licensing of cytotoxic T cells to mediate intestinal epithelial cell lysis. We also demonstrate a role for the cytokine interferon-γ (IFNγ) and the enzyme transglutaminase 2 (TG2) in tissue destruction. By reflecting the complex interaction between gluten, genetics and IL-15-driven tissue inflammation, this mouse model provides the opportunity to both increase our understanding of coeliac disease, and develop new therapeutic strategies.
Figures















Comment in
-
Mimicking coeliac disease in mice.Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):194-195. doi: 10.1038/s41575-020-0285-9. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32123376 No abstract available.
-
Concerns about the histological assessment in a mouse model of human celiac disease.Scand J Immunol. 2024 Mar;99(3):e13351. doi: 10.1111/sji.13351. Epub 2024 Jan 16. Scand J Immunol. 2024. PMID: 38441347
References
-
- Abadie V, Sollid LM, Barreiro LB & Jabri B Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29, 493–525 (2011). - PubMed
-
- Green PH & Cellier C Celiac disease. N Engl J Med 357, 1731–1743 (2007). - PubMed
-
- Jabri B & Sollid LM Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 9, 858–870 (2009). - PubMed
-
- Husby S et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54, 136–160 (2012). - PubMed
Additional References
-
- Pinto D, Robine S, Jaisser F, El Marjou FE & Louvard D Regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of small and large intestines. J Biol Chem 274, 6476–6482 (1999). - PubMed
-
- Lefrancois L & Lycke N Isolation of mouse small intestinal intraepithelial lymphocytes, Peyer’s patch, and lamina propria cells. Curr Protoc Immunol Chapter 3, Unit 3 19 (2001). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials